(Q45148215)

10 December 2017

title

Rosuvastatin alone or with extended-release niacin: a new therapeutic option for patients with combined hyperlipidemia (English)

1 reference

10 December 2017

1 reference

1 reference

David M Capuzzi

1

1 reference

10 December 2017

John M Morgan

2

1 reference

10 December 2017

Christina M Carey

3

1 reference

10 December 2017

Charles Intenzo

4

1 reference

10 December 2017

Thomas Tulenko

5

1 reference

10 December 2017

Dana Kearney

6

1 reference

10 December 2017

Kalen Walker

7

1 reference

10 December 2017

Michael D Cressman

8

1 reference

10 December 2017

publication date

1 January 2004

1 reference

10 December 2017

published in

Preventive Cardiology

1 reference

10 December 2017

volume

7

1 reference

10 December 2017

issue

4

1 reference

10 December 2017

page(s)

176-181

1 reference

Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.3217.X

Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.3217.X

Complementarity of colestipol, niacin, and lovastatin in treatment of severe familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.3217.X

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.3217.X

Effects of extended-release niacin on lipoprotein subclass distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.3217.X

Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.3217.X

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.3217.X

Beneficial effects of rosuvastatin alone and in combination with extended-release niacin in patients with a combined hyperlipidemia and low high-density lipoprotein cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.3217.X

Evaluating niacin in its various forms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.3217.X

Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2004.3217.X

10.1111/J.1520-037X.2004.3217.X

21 January 2018

Identifiers

DOI

1 reference

10 December 2017

1 reference